IV Equipment Market Size, Growth, Share & Trends Analysis
Report Code
MD 5311
Published in
Feb, 2026, By MarketsandMarkets™
IV Equipment Market by Type (IV Catheter, IV Administration Set, Needle-free Connectors), Application (Medication Administration, Parenteral Nutrition, Diagnostic Testing, Blood & Blood Product Transfusion), End User (Hospital) - Global Forecast to 2031
USD 23.92
MARKET SIZE, 2031
CAGR 6.1%
(2026-2031)
400
REPORT PAGES
400
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global IV equipment market is projected to reach USD 23.92 billion by 2031 from USD 17.82 billion in 2026, growing at a CAGR of 6.1% during the forecast period. The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population. The demand for safe and reliable devices is driven by the growing use of IV therapy across hospitals, clinics, and home care settings. The introduction of needle-free connectors and smart infusion systems, together with advancements in the healthcare infrastructure in developing countries, is contributing to the enhanced growth of the market.
KEY TAKEAWAYS
-
HeadingContent
-
BY REGIONThe Asia Pacific is the fastest-growing regional market for IV equipment, at a CAGR of 6.5% during the forecast period.
-
BY TYPEBy type, the IV catheters segment accounted for the largest share of 37.0% of the market in 2025.
-
BY APPLICATIONBy application, the medication administration segment accounted for the largest share of 54.9% of the market in 2025.
-
BY END USERBy end user, the home care settings segment is projected to register the highest CAGR of 7.4% during the forecast period.
-
COMPETITIVE LANDSCAPEBecton, Dickinson and Company; B. Braun SE; and Fresenius SE & Co. KGaA are identified as Star players in the market. These industry leaders have very broad vaccine portfolios, large-scale manufacturing, strong R&D, and global distribution.
-
COMPETITIVE LANDSCAPEINTUVIE HOLDINGS LLC and EPIC Medical are identified as high-growth innovators/SMEs. These companies are carving out niches through regional specialization, novel vaccine technologies, and growing presence in emerging markets.
Data
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The IV equipment market is undergoing a significant transformation, shifting from traditional delivery methods in hospitals to alternatives such as home care, ambulatory surgery centers, and outpatient infusion centers. Traditionally profitable revenue streams are now being replaced by advanced technologies that emphasize digital enhancement and safety, which are relatively new to the market. There is an increasing demand for smart infusion systems, closed-system catheters, portable ambulatory devices, and IV sets with digital monitoring. Providers are focusing on precise dosing, reducing errors, enhancing infection safety, and achieving seamless integration with EHRs. Additionally, emerging use cases such as remote monitoring, specialty drug infusion, and chronic disease management are altering customer expectations and creating opportunities for ecosystem partnerships, new product categories, and targeted mergers & acquisitions. Collectively, these disruptions are setting the stage for strong and diversified revenue growth over the next decade.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Rising disease burden and subsequent surge in geriatric population globally
-
Shift toward home and ambulatory infusion
RESTRAINTS
Impact
Level
Level
-
Product recalls and failures
OPPORTUNITIES
Impact
Level
Level
-
Untapped growth potential in emerging markets
-
Technological advancements and vendor collaborations
CHALLENGES
Impact
Level
Level
-
Device reliability, maintenance requirements, and user-related errors
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
IV EQUIPMENT MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Used in routine peripheral IV access and medication delivery across emergency departments, inpatient wards, and outpatient settings, particularly where high patient throughput and staff safety are critical. | Minimizes needlestick injuries, ensures reliable vascular access, and supports standardized IV practices across hospitals. |
 |
Deployed in continuous and long-duration infusion therapy (ICU, oncology, anesthesia, and surgical recovery), where precise dosing and infection control are essential. | Enables integrated IV workflows, reduces catheter-related infections, and improves infusion accuracy in critical care. |
 |
Applied in high-risk infection environments (ICUs, NICUs, oncology units) to support closed IV systems and needle-free medication administration. | Lowers bloodstream infection rates, enhances clinician safety, and supports hospital infection-prevention protocols. |
 |
Used in acute and chronic infusion treatments, including dialysis centers, ICUs, and long-term care facilities requiring consistent and controlled drug delivery. | Optimizes drug delivery over extended periods and supports continuity of care for chronic patients. |
 |
Utilized for advanced vascular access procedures, including difficult IV insertions, emergency access, and specialty catheter placement in critical care and surgical settings. | Improves insertion success, reduces access-related complications, and shortens procedure time. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The IV equipment market functions within a highly interconnected ecosystem that includes product innovation, regulatory oversight, manufacturing, distribution, and end-user adoption across various care settings. At the heart of this ecosystem are manufacturers, which consist of global device leaders, regional OEMs, and specialized small and medium-sized enterprises (SMEs). These manufacturers create infusion pumps, IV sets, catheters, connectors, and safety-engineered disposables. The innovation efforts of these manufacturers are enhanced by collaborations with academic institutions, clinical research organizations, and technology partners. These collaborations contribute to advancements in material science, smart infusion algorithms, antimicrobial coatings, and interoperable system architectures. Surrounding this network are regulatory agencies such as the FDA, EMA, and national health authorities that enforce strict compliance with safety, sterility, performance standards, and post-market surveillance of medical devices. Ultimately, this ecosystem serves a diverse group of end users, including hospitals, ICUs, oncology centers, surgical departments, ambulatory infusion clinics, and home care providers. The clinical needs, workflow requirements, and safety priorities of these end users directly influence product selection, adoption rates, and the long-term evolution of technology within the market.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
REGION
Asia Pacific to be fastest-growing region in global IV equipment market during forecast period
The Asia Pacific is the fastest-growing market for IV equipment. This growth is driven by several factors, including rising healthcare expenditures, rapidly improving hospital infrastructure, and an increasing prevalence of both chronic and acute diseases. Additionally, rapid urbanization, a growing elderly population, and the greater adoption of advanced IV therapies, such as smart infusion systems and needle-free connectors, are contributing to the surge in demand. Emerging economies in countries like China, India, and other Southeast Asian nations present significant growth opportunities due to enhanced access to healthcare and rising patient volumes.
IV EQUIPMENT MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMPANY EVALUATION MATRIX
In the IV equipment market matrix, Becton, Dickinson and Company (Star) stands out as the global leader, boasting a strong international presence and a comprehensive range of intravenous systems and accessories. Its advanced technologies facilitate rapid adoption in hospitals, clinics, and home care settings. Meanwhile, Moog Inc. (Emerging Leader) is on an accelerated growth trajectory, focusing on innovative and cost-effective IV solutions. The company is working to enhance its presence in emerging markets while also strengthening its position in critical care and home-based infusion therapies.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Becton, Dickinson and Company (US)
- B. Braun SE (Germany)
- Fresenius SE & Co. KGaA (Germany)
- Baxter (US)
- ICU Medical, Inc. (US)
- Terumo Corporation (Japan)
- Moog Inc. (US)
- Teleflex Incorporated (US)
- Cardinal Health (US)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 16.85 Billion |
| Market Forecast in 2031 (Value) | USD 23.92 Billion |
| Growth Rate | CAGR of 6.1% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion), Volume (Thousand Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: IV EQUIPMENT MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | In-depth assessment of IV equipment by product type (IV catheters, infusion pumps, IV sets, connectors, needleless systems), application (medication delivery, fluid management, parenteral nutrition, blood transfusion), and end user (hospitals, ambulatory surgical centers, home healthcare). | Analysis of emerging trends such as smart infusion pumps, closed IV systems, needleless and anti-reflux connectors, antimicrobial-coated catheters, and safety-engineered devices aimed at reducing medication errors and hospital-acquired infections. |
| Company Information | Comprehensive profiles of major global players such as Becton, Dickinson and Company (BD), Baxter International, B. Braun, Fresenius Kabi, ICU Medical, Terumo, and others. | Identification of strategic partnerships, product innovations, regulatory approvals, manufacturing expansions, and mergers & acquisitions shaping competition and technological advancement in the global IV equipment market. |
| Geographic Analysis |
|
Regional market outlook highlighting growth opportunities driven by rising hospitalization rates, increasing chronic disease burden, expansion of home infusion therapy, healthcare infrastructure development in emerging economies, and stricter safety regulations for IV delivery systems worldwide. |
RECENT DEVELOPMENTS
- Heading : Content
- April 2025 : ICU Medical Inc. announced 510(k) regulatory clearance from the US Food and Drug Administration (FDA) for the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. ICU Medical also received 510(k) clearance for updated versions of the Plum Duo precision IV pump and LifeShield infusion safety software, completing the initial launch of the ICU Medical IV Performance Platform.
- April 2025 : The US FDA cleared the BD Alaris Infusion System with Guardrails Suite MX (including modules like PC Unit, Pump, Syringe, PCA, EtCO2, Auto-ID, and System Manager) as safe & effective for market use. This clearance, granted on April 25, 2025, confirms the system is substantially equivalent to previously approved devices and can now be legally sold in the US.
- September 2024 : B. Braun received the US FDA-granted 510(k) clearance for the Introcan Safety 2 Deep Access IV Catheter, the newest addition to the Introcan Safety 2 IV Catheter portfolio.
- April 2024 : Baxter received the US FDA approval for the new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software. These include commercial operations for the most comprehensive infusion system available in the US.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
34
2
EXECUTIVE SUMMARY
40
3
PREMIUM INSIGHTS
45
4
MARKET OVERVIEW
Emerging markets drive IV innovation with smart pumps and home care solutions.
48
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.2.1
DRIVERS
4.2.1.1
RISING DISEASE BURDEN AND SUBSEQUENT SURGE IN GERIATRIC POPULATION GLOBALLY
4.2.1.2
SHIFT TOWARD HOME AND AMBULATORY INFUSION
4.2.1.3
SMART PUMPS, IMPROVED SAFETY FEATURES, AND PRECISION INFUSION SYSTEMS
4.2.2
RESTRAINTS
4.2.2.1
PRODUCT RECALLS AND FAILURES
4.2.2.2
INFECTION AND COMPLICATION RISK ASSOCIATED WITH IV THERAPY
4.2.3
OPPORTUNITIES
4.2.3.1
UNTAPPED GROWTH POTENTIAL IN EMERGING MARKETS
4.2.3.2
TECHNOLOGICAL ADVANCEMENTS AND VENDOR COLLABORATIONS
4.2.4
CHALLENGES
4.2.4.1
DEVICE RELIABILITY, MAINTENANCE REQUIREMENTS, AND USER-RELATED ERRORS
4.3
UNMET NEEDS & WHITE SPACES
4.3.1
UNMET NEEDS IN IV EQUIPMENT MARKET
4.3.1.1
INTEROPERABLE & SMART IV SYSTEMS
4.3.1.2
AFFORDABLE, RELIABLE EQUIPMENT FOR EMERGING MARKETS
4.3.1.3
BETTER INFECTION-PREVENTION DESIGNS
4.3.1.4
HOME CARE & AMBULATORY-FRIENDLY IV DEVICES
4.3.1.5
STREAMLINED REGULATORY PATHWAYS
4.3.1.6
WIDER ACCESS & SUPPLY CONSISTENCY
4.3.2
WHITE SPACE OPPORTUNITIES
4.3.2.1
LOW-COST SMART INFUSION PUMPS FOR EMERGING MARKETS
4.3.2.2
INTEGRATED IV ECOSYSTEM
4.3.2.3
HOME INFUSION & AMBULATORY-FIRST DEVICES
4.3.2.4
INFECTION-PREVENTION IV CONSUMABLES
4.3.2.5
DISPOSABLE/SINGLE-USE SMART COMPONENTS
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.5.1
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and pricing shifts shaping the future of the medical device industry.
57
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS & FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4
TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.4
VALUE CHAIN ANALYSIS
5.5
MARKET ECOSYSTEM
5.5.1
ROLE IN ECOSYSTEM
5.6
PRICING ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF IV EQUIPMENT, BY KEY PLAYER, 2023–2025 (USD)
5.6.2
AVERAGE SELLING PRICE TREND OF INFUSION PUMPS, BY REGION, 2023–2025 (USD)
5.7
TRADE ANALYSIS
5.7.1
IMPORT DATA (HS CODE 901890)
5.7.2
EXPORT DATA (HS CODE 901890)
5.8
REIMBURSEMENT SCENARIO
5.9
KEY CONFERENCES & EVENTS, 2026–2027
5.10
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.11
INVESTMENT & FUNDING SCENARIO
5.12
CASE STUDY ANALYSIS
5.13
IMPACT OF 2025 US TARIFFS ON IV EQUIPMENT MARKET
5.13.1
INTRODUCTION
5.13.2
KEY TARIFF RATES
5.13.3
PRICE IMPACT ANALYSIS
5.13.4
IMPACT ON COUNTRY/REGION
5.13.5
IMPACT ON END-USE SEGMENTS
5.13.5.1
HOSPITALS
5.13.5.2
OUTPATIENT INFUSION & SPECIALTY CLINICS
5.13.5.3
AMBULATORY SURGICAL CENTERS (ASCS)
5.13.5.4
HOME CARE SETTINGS
5.13.5.5
OTHER END USERS (LONG-TERM CARE FACILITIES, EMERGENCY SERVICES, AND SPECIALTY CLINICS)
6
STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION
Harness AI and emerging tech to revolutionize infusion therapy with smart, automated, and safe systems.
80
6.1
TECHNOLOGY ANALYSIS
6.1.1
KEY EMERGING TECHNOLOGIES
6.1.1.1
SMART INFUSION PUMPS
6.1.1.2
CLOSED-LOOP INFUSION CONTROL SYSTEMS
6.1.2
COMPLEMENTARY TECHNOLOGIES
6.1.2.1
DOSE-ERROR REDUCTION SYSTEMS
6.1.2.2
TELEMEDICINE & REMOTE INFUSION MONITORING
6.1.3
ADJACENT TECHNOLOGIES
6.1.3.1
EMBEDDED SOFTWARE
6.2
TECHNOLOGY/PRODUCT ROADMAP
6.2.1
NEAR TERM (2025–2027)
6.2.2
MID TERM (2028–2030)
6.2.3
LONG TERM (2030+)
6.3
PATENT ANALYSIS
6.3.1
JURISDICTION & TOP APPLICANT ANALYSIS
6.4
FUTURE APPLICATIONS
6.4.1
REMOTE & HOME-BASED INFUSION THERAPY
6.4.2
CLOSED-LOOP IV THERAPY & AUTOMATED DOSING
6.4.3
AI-DRIVEN INFUSION SAFETY & PREDICTIVE QUALITY MANAGEMENT
6.5
IMPACT OF AI/GEN AI ON IV EQUIPMENT MARKET
6.5.1
INTRODUCTION
6.5.2
MARKET POTENTIAL OF AI IN IV EQUIPMENT
6.5.3
AI USE CASES
6.5.4
KEY COMPANIES IMPLEMENTING AI
7
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate global regulatory shifts and sustainability trends shaping eco-friendly IV equipment standards.
89
7.1
REGULATORY LANDSCAPE
7.1.1
REGULATORY FRAMEWORK
7.1.1.1
NORTH AMERICA
7.1.1.2
EUROPE
7.1.1.3
ASIA PACIFIC
7.1.1.4
LATIN AMERICA
7.1.1.5
MIDDLE EAST & AFRICA
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3
INDUSTRY STANDARDS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
RECYCLED AND ECO-FRIENDLY MATERIALS FOR IV EQUIPMENT
7.2.2
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.2.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Uncover unmet needs and decision dynamics shaping IV equipment purchasing strategies.
96
8.1
KEY STAKEHOLDERS & BUYING CRITERIA
8.1.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.1.2
BUYING CRITERIA
8.2
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.2.1
DECISION-MAKING PROCESS
8.2.2
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.2.3
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.2.4
MARKET PROFITABILITY
9
IV EQUIPMENT MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
101
9.1
INTRODUCTION
9.2
IV CATHETERS
9.2.1
GROWING HOSPITAL ADMISSIONS AND VASCULAR ACCESS DEMAND TO DRIVE USE OF IV CATHETERS
9.3
INFUSION PUMPS
9.3.1
SHIFT TOWARD PRECISION MEDICINE AND DIGITAL SAFETY TO ACCELERATE SMART PUMP ADOPTION
9.4
IV ADMINISTRATION SETS & TUBING
9.4.1
HIGH-VOLUME THERAPY DEMAND AND SUPPLY CHAIN RESILIENCE TO DRIVE IV SET CONSUMPTION
9.5
SECUREMENT & STABILIZATION DEVICES
9.5.1
GROWING CLINICAL EMPHASIS ON LINE STABILITY AND INFECTION PREVENTION TO ELEVATE SECUREMENT DEMAND
9.6
NEEDLE-FREE CONNECTORS & EXTENSION SETS
9.6.1
NEEDLESTICK PREVENTION AND INFECTION CONTROL POLICIES TO EXPAND CONNECTOR ADOPTION
9.7
IV DRIP CHAMBERS
9.7.1
ESSENTIAL FLOW-CONTROL COMPONENTS TO SUPPORT HIGH-VOLUME GRAVITY INFUSIONS
9.8
OTHER IV EQUIPMENT
10
IV EQUIPMENT MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 24 Data Tables
117
10.1
INTRODUCTION
10.2
MEDICATION ADMINISTRATION
10.2.1
ONCOLOGY (IV CHEMOTHERAPY)
10.2.1.1
RISING CANCER BURDEN TO DRIVE MARKET GROWTH
10.2.2
ANTIBIOTIC/ANTIMICROBIAL IV THERAPY
10.2.2.1
PROLONGED ANTIBIOTIC THERAPY TO BOOST MARKET GROWTH
10.2.3
CRITICAL CARE & VASOACTIVE DRUG INFUSION
10.2.3.1
DEMAND FOR ADVANCED IV PUMPS AND COMPATIBLE DISPOSABLES TO AID MARKET GROWTH
10.2.4
ANALGESIA/PAIN MANAGEMENT
10.2.4.1
SURGE IN CHRONIC PAIN CONDITIONS TO PROPEL MARKET GROWTH
10.2.5
SEDATION & ANESTHESIA INFUSION
10.2.5.1
HIGH PROCEDURAL SEDATION DEMAND TO PROPEL MARKET GROWTH
10.2.6
IMMUNOTHERAPY
10.2.6.1
INCREASING USE IN IMMUNE-MEDIATED CONDITIONS TO SUPPORT MARKET GROWTH
10.3
PARENTERAL NUTRITION (PN)
10.3.1
GASTROINTESTINAL DISORDERS
10.3.1.1
RISING GI DISORDERS TO SUPPORT MARKET GROWTH
10.3.2
CRITICAL CARE NUTRITION
10.3.2.1
INCREASING DEMAND IN ICU UNITS TO SUPPORT MARKET GROWTH
10.3.3
NEONATAL & PEDIATRIC PARENTERAL NUTRITION
10.3.3.1
INCREASING DEMAND FOR NEONATAL LIPID FORMULATIONS TO PROPEL MARKET GROWTH
10.3.4
OTHER PARENTERAL NUTRITION APPLICATIONS
10.4
FLUID & ELECTROLYTE REPLACEMENT
10.4.1
GROWING DEMAND FOR FLUID AND REPLACEMENT THERAPY TO DRIVE MARKET GROWTH
10.5
BLOOD & BLOOD PRODUCTS TRANSFUSION
10.5.1
RED BLOOD CELL TRANSFUSION
10.5.1.1
GROWING USE IN SYMPTOMATIC ANEMIA, ACUTE BLOOD LOSS, AND PERIOPERATIVE BLOOD REPLACEMENT TO SUPPORT MARKET GROWTH
10.5.2
PLATELET TRANSFUSION
10.5.2.1
GROWING USE OF STANDARD BLOOD ADMINISTRATION SETS TO FUEL GROWTH
10.5.3
PLASMA TRANSFUSION
10.5.3.1
WIDE USAGE IN CRITICAL THERAPY FOR COAGULATION DISORDERS TO EXPAND MARKET
10.5.4
OTHER BLOOD & BLOOD PRODUCTS TRANSFUSION APPLICATIONS
10.6
DIAGNOSTIC TESTING
10.6.1
INCREASING DEMAND FOR DIAGNOSTIC IMAGING PROCEDURES TO AID MARKET GROWTH
10.7
OTHER APPLICATIONS
11
IV EQUIPMENT MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
151
11.1
INTRODUCTION
11.2
HOSPITALS
11.2.1
HIGH DEMAND AND COMPLEX INFUSION WORKFLOWS TO SUSTAIN HOSPITAL DOMINANCE IN IV EQUIPMENT USE
11.3
AMBULATORY SURGICAL CENTERS
11.3.1
GROWING NUMBER OF SURGICAL PROCEDURES IN ASCS TO PROPEL MARKET GROWTH
11.4
OUTPATIENT INFUSION & SPECIALTY CLINICS
11.4.1
HIGH DEMAND FOR IV CONSUMABLES AND INFUSION PUMPS TO DRIVE MARKET GROWTH
11.5
HOME CARE SETTINGS
11.5.1
EXPANSION OF HOME INFUSION THERAPY TO CREATE NEW DEMAND FOR PORTABLE IV DEVICES AND CONSUMABLES
11.6
OTHER END USERS
12
IV EQUIPMENT MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 29 Countries | 283 Data Tables.
161
12.1
INTRODUCTION
12.2
NORTH AMERICA
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2
US
12.2.2.1
US TO DOMINATE NORTH AMERICAN IV EQUIPMENT MARKET
12.2.3
CANADA
12.2.3.1
RISING GERIATRIC PATIENT POOL TO DRIVE MARKET GROWTH
12.3
EUROPE
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2
GERMANY
12.3.2.1
INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH
12.3.3
UK
12.3.3.1
RISING ADOPTION OF ADVANCED HEALTHCARE SYSTEMS TO SUPPORT MARKET GROWTH
12.3.4
FRANCE
12.3.4.1
RISING DIGITAL EXPANSION TO PROPEL MARKET GROWTH
12.3.5
ITALY
12.3.5.1
RISING ELDERLY PATIENT POOL TO DRIVE MARKET GROWTH
12.3.6
SPAIN
12.3.6.1
STEADY MODERNIZATION OF HEALTHCARE SYSTEM IN SPAIN TO SUPPORT MARKET GROWTH
12.3.7
NETHERLANDS
12.3.7.1
STRONG HEALTHCARE INFRASTRUCTURE AND AGING POPULATION TO DRIVE MARKET
12.3.8
DENMARK
12.3.8.1
WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO BOOST MARKET
12.3.9
SWEDEN
12.3.9.1
RISING HEALTHCARE EXPENDITURE TO AID MARKET GROWTH
12.3.10
REST OF EUROPE
12.4
ASIA PACIFIC
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2
CHINA
12.4.2.1
GOVERNMENT SUPPORT AND RISING DISEASE BURDEN TO DRIVE MARKET GROWTH
12.4.3
JAPAN
12.4.3.1
HIGH HEALTHCARE EXPENDITURE, FAVORABLE REIMBURSEMENT, AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
12.4.4
INDIA
12.4.4.1
GOVERNMENT INITIATIVES TO PROPEL MARKET GROWTH
12.4.5
SOUTH KOREA
12.4.5.1
RISING AGING POPULATION TO BOLSTER MARKET GROWTH
12.4.6
AUSTRALIA
12.4.6.1
RISING HOSPITALIZATION RATES TO AID MARKET GROWTH
12.4.7
PHILIPPINES
12.4.7.1
GOVERNMENT INVESTMENT AND PUBLIC HOSPITAL MODERNIZATION TO FUEL DEMAND
12.4.8
MALAYSIA
12.4.8.1
RISING HEALTHCARE INVESTMENT AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
12.4.9
VIETNAM
12.4.9.1
GROWING AGING POPULATION AND HEALTHCARE INFRASTRUCTURE DEVELOPMENT TO FUEL MARKET
12.4.10
SINGAPORE
12.4.10.1
ADVANCED HEALTHCARE INFRASTRUCTURE AND TECHNOLOGICAL INTEGRATION TO BOOST MARKET
12.4.11
INDONESIA
12.4.11.1
RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
12.4.12
THAILAND
12.4.12.1
RISING GERIATRIC POPULATION AND CHRONIC DISEASES TO DRIVE MARKET
12.4.13
REST OF ASIA PACIFIC
12.5
LATIN AMERICA
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2
BRAZIL
12.5.2.1
FAVORABLE GOVERNMENT INITIATIVES TO PROPEL MARKET GROWTH
12.5.3
MEXICO
12.5.3.1
RISING DISEASE BURDEN TO AID MARKET GROWTH
12.5.4
ARGENTINA
12.5.4.1
RAPID AGING POPULATION AND SUBSEQUENT RISE IN CHRONIC DISEASES TO BOOST MARKET
12.5.5
COLOMBIA
12.5.5.1
INTEGRATION OF TECHNOLOGICAL ADVANCEMENTS IN HOSPITALS & INFUSION THERAPY SETTINGS TO PROPEL MARKET
12.5.6
CHILE
12.5.6.1
GROWING FOCUS ON LOCAL INFUSION-THERAPY PRODUCT MANUFACTURERS TO FUEL UPTAKE
12.5.7
ECUADOR
12.5.7.1
DIGITAL HEALTH INITIATIVES TO SUPPORT MARKET GROWTH
12.5.8
PERU
12.5.8.1
INCREASING FOCUS ON ONCOLOGY THERAPEUTICS TO BOOST MARKET
12.5.9
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2
GCC COUNTRIES
12.6.2.1
KINGDOM OF SAUDI ARABIA (KSA)
12.6.2.1.1
FAVORABLE GOVERNMENT INITIATIVES TO BOOST GROWTH
12.6.2.2
UNITED ARAB EMIRATES (UAE)
12.6.2.2.1
GOVERNMENT STRATEGIES TO DRIVE MARKET IN UAE
12.6.2.3
REST OF GCC COUNTRIES
12.6.3
REST OF MIDDLE EAST & AFRICA
13
COMPETITIVE LANDSCAPE
Discover strategic insights and market dominance of key players shaping the competitive landscape.
319
13.1
OVERVIEW
13.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
13.3
REVENUE ANALYSIS, 2023–2025
13.4
GLOBAL MARKET SHARE ANALYSIS, 2025
13.4.1
US MARKET SHARE ANALYSIS, 2025
13.4.2
EUROPE MARKET SHARE ANALYSIS, 2025
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1
STARS
13.5.2
EMERGING LEADERS
13.5.3
PERVASIVE PLAYERS
13.5.4
PARTICIPANTS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
TYPE FOOTPRINT
13.5.5.4
APPLICATION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.3
DYNAMIC COMPANIES
13.6.4
STARTING BLOCKS
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
13.7
COMPANY VALUATION & FINANCIAL METRICS
13.7.1
FINANCIAL METRICS
13.7.2
COMPANY VALUATION
13.8
BRAND/PRODUCT COMPARISON
13.9
COMPETITIVE SCENARIO
13.9.1
PRODUCT LAUNCHES & APPROVALS
13.9.2
DEALS
13.9.3
EXPANSIONS
13.9.4
OTHER DEVELOPMENTS
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
336
14.1
KEY PLAYERS
14.1.1
BECTON, DICKINSON AND COMPANY
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.3.1
PRODUCT APPROVALS
14.1.1.3.2
DEALS
14.1.1.3.3
EXPANSIONS
14.1.1.3.4
OTHER DEVELOPMENTS
14.1.1.4
MNM VIEW
14.1.1.4.1
RIGHT TO WIN
14.1.1.4.2
STRATEGIC CHOICES
14.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
14.1.2
B. BRAUN SE
14.1.3
BAXTER
14.1.4
FRESENIUS SE & CO. KGAA
14.1.5
ICU MEDICAL, INC.
14.1.6
TERUMO CORPORATION
14.1.7
MOOG, INC.
14.1.8
TELEFLEX INCORPORATED
14.1.9
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
14.1.10
CARDINAL HEALTH
14.1.11
AVANOS MEDICAL, INC.
14.1.12
NIPRO
14.1.13
JMS CO., LTD.
14.1.14
VYGON
14.1.15
MICREL MEDICAL DEVICES SA
14.2
OTHER PLAYERS
14.2.1
ARCOMED
14.2.2
HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
14.2.3
EITAN MEDICAL
14.2.4
ANGIPLAST PRIVATE LIMITED
14.2.5
PRIMEGUARD MEDICAL
14.2.6
IRADIMED CORPORATION
14.2.7
EPIC MEDICAL
14.2.8
ROMSONS
14.2.9
BEIJING KELLYMED CO., LTD.
14.2.10
INTUVIE HOLDINGS LLC
14.2.11
PROMED TECHNOLOGY CO., LIMITED
14.2.12
MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD.
15
RESEARCH METHODOLOGY
401
15.1
RESEARCH APPROACH
15.2
RESEARCH METHODOLOGY DESIGN
15.2.1
SECONDARY RESEARCH
15.2.1.1
KEY DATA FROM SECONDARY SOURCES
15.2.2
PRIMARY DATA
15.2.2.1
KEY INDUSTRY INSIGHTS
15.3
MARKET SIZE ESTIMATION
15.3.1
BOTTOM-UP APPROACH
15.4
MARKET BREAKDOWN & DATA TRIANGULATION
15.5
MARKET SHARE ESTIMATION
15.6
ASSUMPTIONS
15.6.1
GROWTH RATE ASSUMPTIONS
15.7
RISK ASSESSMENT
15.8
LIMITATIONS
15.8.1
METHODOLOGY-RELATED LIMITATIONS
15.8.2
SCOPE-RELATED LIMITATIONS
16
APPENDIX
415
16.1
DISCUSSION GUIDE
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
16.3.1
COMPANY INFORMATION
16.3.2
GEOGRAPHIC ANALYSIS
16.3.3
REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
16.3.4
COUNTRY-LEVEL VOLUME ANALYSIS
16.3.5
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST
16.4
RELATED REPORTS
16.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
IV EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3
IV EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4
GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 5
IV EQUIPMENT MARKET: ROLE IN ECOSYSTEM
TABLE 6
AVERAGE SELLING PRICE TREND OF IV EQUIPMENT, BY KEY PLAYER, 2023–2025 (USD)
TABLE 7
AVERAGE SELLING PRICE TREND OF INFUSION PUMPS, BY REGION, 2023–2025 (USD)
TABLE 8
IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (HS CODE 901890), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 9
EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (HS CODE 901890), BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 10
IV EQUIPMENT MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027
TABLE 11
CASE STUDY 1: NEXT-GENERATION INTRAVENOUS (IV) INFUSION PUMPS
TABLE 12
CASE STUDY 2: PREVENTING IV CATHETER DISLODGMENT IN PEDIATRIC NEUROSURGERY
TABLE 13
CASE STUDY 3: INFUSION PUMP INTEROPERABILITY TRANSFORMS MEDICATION SAFETY
TABLE 14
US-ADJUSTED RECIPROCAL TARIFF RATES, 2024
TABLE 15
KEY PRODUCT-RELATED TARIFFS EFFECTIVE
TABLE 16
NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA
TABLE 17
ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA
TABLE 18
EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK
TABLE 19
LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO
TABLE 20
IV EQUIPMENT MARKET: KEY PATENTS, 2023–2025
TABLE 21
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26
INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF IV EQUIPMENT
TABLE 27
KEY BUYING CRITERIA FOR IV EQUIPMENT, BY TYPE
TABLE 28
IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 29
COMMERCIAL IV CATHETERS AVAILABLE IN MARKET
TABLE 30
IV CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31
COMMERCIAL INFUSION PUMPS AVAILABLE IN MARKET
TABLE 32
INFUSION PUMPS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33
COMMERCIAL IV ADMINISTRATION SETS & TUBING AVAILABLE IN MARKET
TABLE 34
IV ADMINISTRATION SETS & TUBING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
COMMERCIAL SECUREMENT & STABILIZATION DEVICES AVAILABLE IN MARKET
TABLE 36
SECUREMENT & STABILIZATION DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
COMMERCIAL NEEDLE-FREE CONNECTORS & EXTENSION SETS AVAILABLE IN MARKET
TABLE 38
NEEDLE-FREE CONNECTORS & EXTENSION SETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
COMMERCIAL IV DRIP CHAMBERS AVAILABLE IN MARKET
TABLE 40
IV DRIP CHAMBERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
COMMERCIAL OTHER IV EQUIPMENT AVAILABLE IN MARKET
TABLE 42
OTHER IV EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43
IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 44
IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 45
IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46
IV EQUIPMENT MARKET FOR ONCOLOGY (IV CHEMOTHERAPY), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47
IV EQUIPMENT MARKET FOR ANTIBIOTIC/ANTIMICROBIAL IV THERAPY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48
IV EQUIPMENT MARKET FOR CRITICAL CARE & VASOACTIVE DRUG INFUSION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
IV EQUIPMENT MARKET FOR ANALGESIA/PAIN MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
IV EQUIPMENT MARKET FOR SEDATION & ANESTHESIA INFUSION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
IV EQUIPMENT MARKET FOR IMMUNOTHERAPY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52
IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION (PN), BY TYPE, 2024–2031 (USD MILLION)
TABLE 53
IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION (PN), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
IV EQUIPMENT MARKET FOR GASTROINTESTINAL DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
IV EQUIPMENT MARKET FOR CRITICAL CARE NUTRITION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
IV EQUIPMENT MARKET FOR NEONATAL & PEDIATRIC PARENTERAL NUTRITION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57
IV EQUIPMENT MARKET FOR OTHER PARENTERAL NUTRITION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58
IV EQUIPMENT MARKET FOR FLUID & ELECTROLYTE REPLACEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 60
IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61
IV EQUIPMENT MARKET FOR RED BLOOD CELL TRANSFUSION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62
IV EQUIPMENT MARKET FOR PLATELET TRANSFUSION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63
IV EQUIPMENT MARKET FOR PLASMA TRANSFUSION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64
IV EQUIPMENT MARKET FOR OTHER BLOOD & BLOOD PRODUCTS TRANSFUSION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65
IV EQUIPMENT MARKET FOR DIAGNOSTIC TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66
IV EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67
IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 68
IV EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69
IV EQUIPMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70
IV EQUIPMENT MARKET FOR OUTPATIENT INFUSION & SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71
IV EQUIPMENT MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72
IV EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73
IV EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 74
IV CATHETERS MARKET, BY REGION, 2024–2031 (MILLION UNITS)
TABLE 75
INFUSION PUMPS MARKET, BY REGION, 2024–2031 (MILLION UNITS)
TABLE 76
IV ADMINISTRATION SETS & TUBING MARKET, BY REGION, 2024–2031 (MILLION UNITS)
TABLE 77
NORTH AMERICA: IV EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78
NORTH AMERICA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 79
NORTH AMERICA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 80
NORTH AMERICA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 81
NORTH AMERICA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 82
NORTH AMERICA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83
NORTH AMERICA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 84
US: KEY MACROECONOMIC INDICATORS
TABLE 85
US: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 86
US: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 87
US: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 88
US: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89
US: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90
US: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 91
CANADA: KEY MACROECONOMIC INDICATORS
TABLE 92
CANADA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93
CANADA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 94
CANADA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95
CANADA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96
CANADA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
CANADA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 98
EUROPE: IV EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99
EUROPE: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100
EUROPE: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 101
EUROPE: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102
EUROPE: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
EUROPE: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104
EUROPE: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 105
GERMANY: KEY MACROECONOMIC INDICATORS
TABLE 106
GERMANY: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107
GERMANY: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 108
GERMANY: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
GERMANY: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110
GERMANY: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111
GERMANY: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 112
UK: KEY MACROECONOMIC INDICATORS
TABLE 113
UK: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114
UK: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 115
UK: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116
UK: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117
UK: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118
UK: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 119
FRANCE: KEY MACROECONOMIC INDICATORS
TABLE 120
FRANCE: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121
FRANCE : IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 122
FRANCE : IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123
FRANCE: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124
FRANCE: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125
FRANCE: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 126
ITALY: KEY MACROECONOMIC INDICATORS
TABLE 127
ITALY: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128
ITALY: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 129
ITALY: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130
ITALY: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131
ITALY: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 132
ITALY: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 133
SPAIN: KEY MACROECONOMIC INDICATORS
TABLE 134
SPAIN: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
SPAIN: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 136
SPAIN: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137
SPAIN: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138
SPAIN: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139
SPAIN: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 140
NETHERLANDS: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141
NETHERLANDS: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 142
NETHERLANDS: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143
NETHERLANDS: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144
NETHERLANDS: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
NETHERLANDS: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 146
DENMARK: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147
DENMARK: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 148
DENMARK: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149
DENMARK: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150
DENMARK: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151
DENMARK: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 152
SWEDEN: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153
SWEDEN: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 154
SWEDEN: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155
SWEDEN: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156
SWEDEN: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157
SWEDEN: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 158
REST OF EUROPE: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 159
REST OF EUROPE: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 160
REST OF EUROPE: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161
REST OF EUROPE: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 162
REST OF EUROPE: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163
REST OF EUROPE: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 164
ASIA PACIFIC: IV EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165
ASIA PACIFIC: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166
ASIA PACIFIC: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 167
ASIA PACIFIC: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168
ASIA PACIFIC: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169
ASIA PACIFIC: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 170
ASIA PACIFIC: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 171
CHINA: KEY MACROECONOMIC INDICATORS
TABLE 172
CHINA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173
CHINA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 174
CHINA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175
CHINA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176
CHINA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177
CHINA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 178
JAPAN: KEY MACROECONOMIC INDICATORS
TABLE 179
JAPAN: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180
JAPAN: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 181
JAPAN: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182
JAPAN: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183
JAPAN: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184
JAPAN: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185
INDIA: KEY MACROECONOMIC INDICATORS
TABLE 186
INDIA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187
INDIA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 188
INDIA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189
INDIA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190
INDIA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191
INDIA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 192
SOUTH KOREA: KEY MACROECONOMIC INDICATORS
TABLE 193
SOUTH KOREA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194
SOUTH KOREA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 195
SOUTH KOREA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196
SOUTH KOREA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197
SOUTH KOREA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198
SOUTH KOREA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199
AUSTRALIA: KEY MACROECONOMIC INDICATORS
TABLE 200
AUSTRALIA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201
AUSTRALIA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 202
AUSTRALIA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203
AUSTRALIA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204
AUSTRALIA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205
AUSTRALIA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206
PHILIPPINES: KEY MACROECONOMIC INDICATORS
TABLE 207
PHILIPPINES: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208
PHILIPPINES: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 209
PHILIPPINES: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210
PHILIPPINES: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211
PHILIPPINES: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212
PHILIPPINES: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 213
MALAYSIA: KEY MACROECONOMIC INDICATORS
TABLE 214
MALAYSIA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
MALAYSIA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 216
MALAYSIA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217
MALAYSIA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 218
MALAYSIA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219
MALAYSIA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 220
VIETNAM: KEY MACROECONOMIC INDICATORS
TABLE 221
VIETNAM: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222
VIETNAM: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 223
VIETNAM: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 224
VIETNAM: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225
VIETNAM: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
VIETNAM: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 227
SINGAPORE: KEY MACROECONOMIC INDICATORS
TABLE 228
SINGAPORE: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229
SINGAPORE: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 230
SINGAPORE: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
SINGAPORE: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232
SINGAPORE: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233
SINGAPORE: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 234
INDONESIA: KEY MACROECONOMIC INDICATORS
TABLE 235
INDONESIA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236
INDONESIA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 237
INDONESIA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238
INDONESIA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239
INDONESIA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240
INDONESIA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 241
THAILAND: KEY MACROECONOMIC INDICATORS
TABLE 242
THAILAND: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243
THAILAND: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 244
THAILAND: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245
THAILAND: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246
THAILAND: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247
THAILAND: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 248
REST OF ASIA PACIFIC: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 249
REST OF ASIA PACIFIC: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 250
REST OF ASIA PACIFIC: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251
REST OF ASIA PACIFIC: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252
REST OF ASIA PACIFIC: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 253
REST OF ASIA PACIFIC: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 254
LATIN AMERICA: IV EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 255
LATIN AMERICA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256
LATIN AMERICA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 257
LATIN AMERICA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258
LATIN AMERICA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259
LATIN AMERICA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 260
LATIN AMERICA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 261
BRAZIL: KEY MACROECONOMIC INDICATORS
TABLE 262
BRAZIL: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263
BRAZIL: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 264
BRAZIL: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265
BRAZIL: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266
BRAZIL: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267
BRAZIL: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 268
MEXICO: KEY MACROECONOMIC INDICATORS
TABLE 269
MEXICO: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270
MEXICO: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 271
MEXICO: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272
MEXICO: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273
MEXICO: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274
MEXICO: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 275
ARGENTINA: KEY MACROECONOMIC INDICATORS
TABLE 276
ARGENTINA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277
ARGENTINA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 278
ARGENTINA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 279
ARGENTINA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 280
ARGENTINA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281
ARGENTINA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 282
COLOMBIA: KEY MACROECONOMIC INDICATORS
TABLE 283
COLOMBIA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 284
COLOMBIA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 285
COLOMBIA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286
COLOMBIA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287
COLOMBIA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288
COLOMBIA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 289
CHILE: KEY MACROECONOMIC INDICATORS
TABLE 290
CHILE: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291
CHILE: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 292
CHILE: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293
CHILE: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294
CHILE: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295
CHILE: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 296
ECUADOR: KEY MACROECONOMIC INDICATORS
TABLE 297
ECUADOR: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298
ECUADOR: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 299
ECUADOR: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 300
ECUADOR: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 301
ECUADOR: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 302
ECUADOR: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 303
PERU: KEY MACROECONOMIC INDICATORS
TABLE 304
PERU: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305
PERU: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 306
PERU: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307
PERU: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308
PERU: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309
PERU: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 310
REST OF LATIN AMERICA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 311
REST OF LATIN AMERICA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 312
REST OF LATIN AMERICA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 313
REST OF LATIN AMERICA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314
REST OF LATIN AMERICA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315
REST OF LATIN AMERICA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 316
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 317
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 319
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 320
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 321
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 322
MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 323
GCC COUNTRIES: IV EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 324
GCC COUNTRIES: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 325
GCC COUNTRIES: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 326
GCC COUNTRIES: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 327
GCC COUNTRIES: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 328
GCC COUNTRIES: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 329
GCC COUNTRIES: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 330
KINGDOM OF SAUDI ARABIA: KEY MACROECONOMIC INDICATORS
TABLE 331
KINGDOM OF SAUDI ARABIA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 332
KINGDOM OF SAUDI ARABIA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 333
KINGDOM OF SAUDI ARABIA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 334
KINGDOM OF SAUDI ARABIA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 335
KINGDOM OF SAUDI ARABIA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 336
KINGDOM OF SAUDI ARABIA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 337
UAE: KEY MACROECONOMIC INDICATORS
TABLE 338
UAE: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 339
UAE: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 340
UAE: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 341
UAE: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 342
UAE: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 343
UAE: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 344
REST OF GCC COUNTRIES: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 345
REST OF GCC COUNTRIES: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 346
REST OF GCC COUNTRIES: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 347
REST OF GCC COUNTRIES: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 348
REST OF GCC COUNTRIES: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 349
REST OF GCC COUNTRIES: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 350
REST OF MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 351
REST OF MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 352
REST OF MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET FOR MEDICATION ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 353
REST OF MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 354
REST OF MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET FOR BLOOD & BLOOD PRODUCTS TRANSFUSION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 355
REST OF MIDDLE EAST & AFRICA: IV EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 356
OVERVIEW OF STRATEGIES ADOPTED BY KEY IV EQUIPMENT MANUFACTURING COMPANIES
TABLE 357
GLOBAL IV EQUIPMENT MARKET: DEGREE OF COMPETITION
TABLE 358
IV EQUIPMENT MARKET: REGION FOOTPRINT
TABLE 359
IV EQUIPMENT MARKET: TYPE FOOTPRINT
TABLE 360
IV EQUIPMENT MARKET: APPLICATION FOOTPRINT
TABLE 361
IV EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 362
IV EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
TABLE 363
IV EQUIPMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 364
IV EQUIPMENT MARKET: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 365
IV EQUIPMENT MARKET: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 366
IV EQUIPMENT MARKET: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 367
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 368
BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 369
BECTON, DICKINSON AND COMPANY: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 370
BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 371
BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 372
BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 373
B. BRAUN SE: COMPANY OVERVIEW
TABLE 374
B. BRAUN SE: PRODUCTS OFFERED
TABLE 375
B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–NOVEMBER 2025
TABLE 376
B. BRAUN SE: DEALS, JANUARY 2022−DECEMBER 2025
TABLE 377
BAXTER: COMPANY OVERVIEW
TABLE 378
BAXTER: PRODUCTS OFFERED
TABLE 379
BAXTER: PRODUCT APPROVALS, JANUARY 2022−NOVEMBER 2025
TABLE 380
BAXTER: DEALS, JANUARY 2022−NOVEMBER 2025
TABLE 381
FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
TABLE 382
FRESENIUS SE & CO. KGAA: PRODUCTS OFFERED
TABLE 383
FRESENIUS SE & CO. KGAA: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 384
FRESENIUS SE & CO. KGAA: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 385
ICU MEDICAL, INC.: COMPANY OVERVIEW
TABLE 386
ICU MEDICAL, INC.: PRODUCTS OFFERED
TABLE 387
ICU MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 388
ICU MEDICAL, INC.: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 389
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 390
TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 391
TERUMO CORPORATION: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 392
TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 393
MOOG INC.: COMPANY OVERVIEW
TABLE 394
MOOG INC.: PRODUCTS OFFERED
TABLE 395
MOOG INC.: PRODUCT APPROVALS, JANUARY 2022–DECEMBER 2025
TABLE 396
TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 397
TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 398
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 399
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
TABLE 400
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025
TABLE 401
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025
TABLE 402
CARDINAL HEALTH: COMPANY OVERVIEW
TABLE 403
CARDINAL HEALTH: PRODUCTS OFFERED
TABLE 404
CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 405
AVANOS MEDICAL, INC.: COMPANY OVERVIEW
TABLE 406
AVANOS MEDICAL, INC.: PRODUCTS OFFERED
TABLE 407
NIPRO: COMPANY OVERVIEW
TABLE 408
NIPRO: PRODUCTS OFFERED
TABLE 409
NIPRO: EXPANSIONS, JANUARY 2022–DECEMBER 2025
TABLE 410
JMS CO., LTD.: COMPANY OVERVIEW
TABLE 411
JMS CO., LTD.: PRODUCTS OFFERED
TABLE 412
VYGON: COMPANY OVERVIEW
TABLE 413
VYGON: PRODUCTS OFFERED
TABLE 414
VYGON: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 415
MICREL MEDICAL DEVICES SA: COMPANY OVERVIEW
TABLE 416
MICREL MEDICAL DEVICES SA: PRODUCTS OFFERED
TABLE 417
MICREL MEDICAL DEVICES SA: DEALS, JANUARY 2022–DECEMBER 2025
TABLE 418
ARCOMED: COMPANY OVERVIEW
TABLE 419
HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: COMPANY OVERVIEW
TABLE 420
EITAN MEDICAL: COMPANY OVERVIEW
TABLE 421
ANGIPLAST PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 422
PRIMEGUARD MEDICAL: COMPANY OVERVIEW
TABLE 423
IRADIMED CORPORATION: COMPANY OVERVIEW
TABLE 424
EPIC MEDICAL: COMPANY OVERVIEW
TABLE 425
ROMSONS: COMPANY OVERVIEW
TABLE 426
BEIJING KELLYMED CO., LTD.: COMPANY OVERVIEW
TABLE 427
INTUVIE HOLDINGS LLC: COMPANY OVERVIEW
TABLE 428
PROMED TECHNOLOGY CO., LIMITED: COMPANY OVERVIEW
TABLE 429
MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 430
RISK ASSESSMENT: IV EQUIPMENT MARKET
LIST OF FIGURES
FIGURE 1
IV EQUIPMENT MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
FIGURE 2
IV EQUIPMENT MARKET: YEARS CONSIDERED
FIGURE 3
MARKET SCENARIO
FIGURE 4
GLOBAL IV EQUIPMENT MARKET, 2024–2031
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN IV EQUIPMENT MARKET, 2022–2025
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF IV EQUIPMENT MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS IN IV EQUIPMENT MARKET, 2026–2031
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN IV EQUIPMENT MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9
GROWING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
FIGURE 10
HOSPITALS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2025
FIGURE 11
CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 12
IV EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13
IV EQUIPMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 14
IV EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 15
IV EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 16
IV EQUIPMENT MARKET ECOSYSTEM
FIGURE 17
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 18
INVESTMENT & FUNDING SCENARIO FOR IV EQUIPMENT MARKET PLAYERS
FIGURE 19
TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR INFUSION PUMP PATENTS (JANUARY 2014–DECEMBER 2025)
FIGURE 20
IV EQUIPMENT MARKET: AI USE CASES
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IV EQUIPMENT
FIGURE 22
KEY BUYING CRITERIA FOR IV EQUIPMENT, BY TYPE
FIGURE 23
NORTH AMERICA: IV EQUIPMENT MARKET SNAPSHOT
FIGURE 24
ASIA PACIFIC: IV EQUIPMENT MARKET SNAPSHOT
FIGURE 25
REVENUE ANALYSIS OF KEY PLAYERS IN IV EQUIPMENT MARKET, 2023–2025
FIGURE 26
GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS IN IV EQUIPMENT MARKET, 2025
FIGURE 27
US MARKET SHARE ANALYSIS OF KEY PLAYERS IN IV EQUIPMENT MARKET, 2025
FIGURE 28
EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN IV EQUIPMENT MARKET, 2025
FIGURE 29
IV EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30
IV EQUIPMENT MARKET: COMPANY FOOTPRINT
FIGURE 31
IV EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32
EV/EBITDA OF KEY VENDORS
FIGURE 33
YEAR-TO-DATE PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 34
IV EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON
FIGURE 35
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2025)
FIGURE 36
B. BRAUN SE: COMPANY SNAPSHOT (2024)
FIGURE 37
BAXTER: COMPANY SNAPSHOT (2024)
FIGURE 38
FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2024)
FIGURE 39
ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)
FIGURE 40
TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 41
MOOG INC.: COMPANY SNAPSHOT (2024)
FIGURE 42
TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024)
FIGURE 43
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2024)
FIGURE 44
CARDINAL HEALTH: COMPANY SNAPSHOT (2025)
FIGURE 45
AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2024)
FIGURE 46
NIPRO: COMPANY SNAPSHOT (2024)
FIGURE 47
JMS CO., LTD.: COMPANY SNAPSHOT (2024)
FIGURE 48
IV EQUIPMENT MARKET: RESEARCH DESIGN
FIGURE 49
PRIMARY SOURCES
FIGURE 50
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 51
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 52
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 53
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 54
REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY
FIGURE 55
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF IV EQUIPMENT MARKET (2025–2030)
FIGURE 56
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 57
TOP-DOWN APPROACH
FIGURE 58
BOTTOM-UP APPROACH
FIGURE 59
MARKET DATA TRIANGULATION METHODOLOGY
Methodology
This study relied heavily on both primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and company SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IV equipment market. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the IV equipment market. The primary demand-side sources include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.
Breakdown of Primary Interviews:
A breakdown of the primary respondents for the IV equipment market (supply side) is provided below:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion,
Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In this report, the global IV equipment market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the IV equipment business were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.
To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involved the following steps:
- Generating a list of major global players operating in the IV equipment market
- Mapping annual revenues generated by major global players from the IV equipment segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the IV equipment industry
Global IV Equipment Market Size: Top-down & Bottom-up Approach
IV Equipment Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size through the market size estimation process explained above, the global IV equipment market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the IV equipment market was validated using both top-down and bottom-up approaches.
Market Definition
IV equipment refers to the complete set of medical devices, accessories, and consumables used to deliver fluids, medications, nutrients, and blood products directly into a patient’s bloodstream through intravenous (IV) access. It includes infusion pumps, IV administration sets, catheters and cannulas, needle-free connectors, extension sets, securement devices, and related safety components designed to ensure accurate, controlled, and sterile delivery of therapies in hospitals, outpatient centers, and home care settings. IV equipment is essential for hydration, drug infusion, chemotherapy, parenteral nutrition, anesthesia, critical care, and emergency treatment.
Key Stakeholders
- Manufacturers of IV equipment
- Distributors of IV equipment
- Hospitals, clinics, and infusion centers
- Ambulatory surgery centers
- Non-government organizations
- Government regulatory authorities
- Contract manufacturers & third-party suppliers
- Research laboratories & academic institutes
- Clinical research organizations (CROs)
- Government & non-governmental regulatory authorities
- Market research & consulting firms
Report Objectives
- To define, describe, and forecast the IV equipment market based on type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global IV equipment market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global IV equipment market
- To analyze key growth opportunities in the global IV equipment market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the global IV equipment market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the global IV equipment market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global IV equipment market, such as agreements, collaborations, partnerships, expansions, and acquisitions
Customization Options
Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the present global IV equipment market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies
Company Information
- Detailed analysis and profiling of additional market players (up to 10)
Geographic Analysis
- Further breakdown of the Rest of Europe IV equipment market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, and Belgium
- Further breakdown of the Rest of Asia Pacific IV equipment market into Taiwan, New Zealand, and Sri Lanka
- Further breakdown of the Rest of Latin America IV equipment market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
Fact checked
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the IV Equipment Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Still Researching the
IV Equipment Ecosystem?
See the competitors, opportunity evaluation, and growth signals shaping it - Instantly!
Generate 15+ consulting-grade strategic intelligence outputs - from competitor analysis to board-ready strategy decks, tailored to your IV Equipment growth question.
Growth opportunities and latent adjacency in IV Equipment Market